The relationship between fatigability and sleep quality in people with multiple sclerosis [0.03%]
多发性硬化患者疲劳与睡眠质量的关系
Mayis Aldughmi,Jessie Huisinga,Sharon G Lynch et al.
Mayis Aldughmi et al.
Background: Perceived fatigue and fatigability are constructs of multiple sclerosis (MS)-related fatigue. Sleep disturbances lead to poor sleep quality, which has been found to be associated with perceived fatigue in peop...
Randomized controlled trial of exercise interventions to improve sleep quality and daytime sleepiness in individuals with multiple sclerosis: A pilot study [0.03%]
多发性硬化症患者的运动干预改善睡眠质量及日间嗜睡的随机对照试验——一项试点研究
Catherine F Siengsukon,Mayis Aldughmi,Melike Kahya et al.
Catherine F Siengsukon et al.
Background: Nearly 70% of individuals with multiple sclerosis (MS) experience sleep disturbances. Increasing physical activity in people with MS has been shown to produce a moderate improvement in sleep quality, and exerc...
Coping strategies in relation to negative work events and accommodations in employed multiple sclerosis patients [0.03%]
与消极工作事件和就业多发性硬化症患者有关的应对策略及适应能力
K van der Hiele,Dam van Gorp,Rhb Benedict et al.
K van der Hiele et al.
Background: Job loss is common in multiple sclerosis (MS) and is known to exert a negative effect on quality of life. The process leading up to job loss typically includes negative work events, productivity losses and a n...
Mary Ann Harp,Kevin K McCully,Marina Moldavskiy et al.
Mary Ann Harp et al.
Background: People with multiple sclerosis (MS) have functional disability and may have reduced muscle mitochondrial capacity. Objective: ...
Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis [0.03%]
Peginterferon β-1a可改善多发性硬化症患者的复发恢复状况
Thomas F Scott,Bernd C Kieseier,Scott D Newsome et al.
Thomas F Scott et al.
Background: Subcutaneous peginterferon beta-1a every 2 weeks significantly affects clinical outcomes in patients with relapsing-remitting multiple sclerosis (RRMS). ...
Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India [0.03%]
印度抗髓鞘少突胶质细胞糖蛋白抗体患者的临床表型以视神经炎复发和单相横贯性脊髓炎为主
Lekha Pandit,Douglas Kazutoshi Sato,Sharik Mustafa et al.
Lekha Pandit et al.
Background: Clinical phenotypes of patients with antibodies to myelin oligodendrocyte glycoprotein (anti-MOG+) are unknown in India. Objectives: ...
Analysis of the psychometric properties of the Multiple Sclerosis Impact Scale-29 (MSIS-29) in relapsing-remitting multiple sclerosis using classical and modern test theory [0.03%]
经典和现代测试理论在复发缓解型多发性硬化症中分析Multiple Sclerosis Impact Scale-29 (MSIS-29)的心理测量属性
E D Bacci,K W Wyrwich,G A Phillips et al.
E D Bacci et al.
Background: Investigations using classical test theory support the psychometric properties of the original version of the Multiple Sclerosis Impact Scale (MSIS-29v1), a disease-specific measure of multiple sclerosis (MS) ...
Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis [0.03%]
小剂量纳曲酮的长期治疗维持多发性硬化患者的健康状态
Michael D Ludwig,Anthony P Turel,Ian S Zagon et al.
Michael D Ludwig et al.
Introduction: A retrospective study was conducted on patients at Penn State Hershey Medical Center diagnosed with relapsing-remitting multiple sclerosis between 2006 and 2015. ...
Experience with long-term rituximab use in a multiple sclerosis clinic [0.03%]
利妥昔单抗在多发性硬化症患者中的长期应用经验
Megan E Barra,Dhruv Soni,Khac Huy Vo et al.
Megan E Barra et al.
Background: Rituximab is a monoclonal antibody directed at CD20 positive B-lymphocytes and a potential therapeutic option in the treatment of multiple sclerosis. The safety of recurrent dosing is not established. ...
Prevalence of multiple sclerosis in Latin America and its relationship with European migration [0.03%]
拉丁美洲多发性硬化的流行率及其与欧洲移民的关系
Edgar Correa,Víctor Paredes,Braulio Martínez
Edgar Correa
Multiple sclerosis (MS) is a chronic, degenerative autoimmune inflammatory disease of the central nervous system. The prevalence is different in every continent, changing according to geographical and environmental characteristics. The area...